IDEAL MAILING LIST
Sign up for information on the next Ideal Experience click here

P2P IDEAL®: Telephonic Teaching Rounds Updates
Sign up for the next Teaching Rounds Updates Click Here

Course Materials (Online Syllabus)

Below you will find the educational information presented during the IDEAL CME/CE activity November 12-14, 2010 at the AHA 2010 conference. This material is provided for your information only. CME/CE credit was offered for participating during the live event only.

To download a PDF copy of the panels and transcripts, click here
To download a PDF copy of the clinical pearls only, click here

PROGRAM PANELS
Panel 1: Pathway to Diagnosis and Management in Atrial Fibrillation
References can be found on the
Resources page
Panel 1: Pathway to Diagnosis and Management in Atrial Fibrillation
What is the first treatment priority when treating a patient with atrial fibrillation?
Listen to full audio

Alternatively you can listen to individual parts:
      Listen to commentary
      Listen to answer
      Listen to clinical pearl

---
Panel 2: Assessing and Mitigating Risk in Stroke Prevention
References can be found on the
Resources page
Panel 2: Assessing and Mitigating Risk in Stroke Prevention
What is the CHADS2 score and risk of stroke for a 76-year-old woman with atrial fibrillation and blood pressure of 145/100??
Listen to full audio

Alternatively you can listen to individual parts:
      Listen to commentary
      Listen to answer
      Listen to clinical pearl

---
Panel 3: Rate Control
References can be found on the
Resources page
Panel 3: Rate Control
If cardioversion was unsuccessful and a decision is made to allow atrial fibrillation to continue uncorrected, what is the arrhythmia classified as?
Listen to full audio

Alternatively you can listen to individual parts:
      Listen to commentary
      Listen to answer
      Listen to clinical pearl

---
Panel 4: Stroke Prevention
References can be found on the
Resources page
Panel 4: Stroke Prevention
If a patient who has required a stable dose of warfarin develops an INR of 3.5, what is the next step?
Listen to full audio

Alternatively you can listen to individual parts:
      Listen to commentary
      Listen to answer
      Listen to clinical pearl

---
Panel 5: Novel Approaches to Stroke Prevention
References can be found on the
Resources page
Panel 5: Novel Approaches to Stroke Prevention
If switching a patient to a new oral direct thrombin inhibitor or Factor Xa inhibitor, when should the new agent be started after stopping warfarin?
Listen to full audio

Alternatively you can listen to individual parts:
      Listen to commentary
      Listen to answer
      Listen to clinical pearl

---
Panel 6: Rhythm Control
References can be found on the
Resources page
Panel 6: Rhythm Control
Does restoring sinus rhythm enable patients to discontinue antithrombotic therapy?
Listen to full audio

Alternatively you can listen to individual parts:
      Listen to commentary
      Listen to answer
      Listen to clinical pearl

---
Panel 7: Create a Foundation for Partnership in Care
References can be found on the
Resources page
Panel 7: Create a Foundation for Partnership in Care
When discussing rhythm control strategies, how often should you communicate with patients the need to continue antithrombotic therapy for stroke prevention?
Listen to full audio

Alternatively you can listen to individual parts:
      Listen to commentary
      Listen to answer
      Listen to clinical pearl

---

Commercial Support Statement

The live certified CME/CE activity presented at the American Heart Association 2010 Scientific Sessions was supported by educational grants provided by Boehringer Ingelheim, Ortho-McNeil, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc, administered by Ortho-McNeil Janssen Scientific Affairs, LLC, and Bristol-Myers Squibb and Pfizer, Inc.